Pearls

Off-label prescribing: How to limit your liability

Author and Disclosure Information

 

References

The FDA defines “off-label” prescribing as prescribing an FDA-approved medication for an unapproved use, such as for an unapproved clinical indication, for a higher-than-approved dose, or for a patient who is not part of the FDA-approved population (eg, children or geriatric patients).1 Off-label prescribing is common in psychiatry; approximately 13% of psychiatry patients are prescribed off-label psychotropic medications.2 The American Psychiatric Association strongly supports “the autonomous clinical decision-making authority of a physician” and “a physician’s lawful use of an FDA-approved drug product or medical device for an off-label indication when such use is based upon sound scientific evidence in conjunction with sound medical judgment.”3 Because many psychiatric diagnoses have no FDA-approved medications, off-label prescribing often may be a psychiatrist’s only pharmacologic option.

Unfortunately, off-label prescribing can increase a psychiatrist’s risk for liability when treatment falls short of patients’ expectations, or when patients allege that they were injured by the use of an off-label medication. Off-label prescribing does not automatically lead to losing a malpractice suit because the FDA states that physicians can prescribe approved medications for any scientifically supported use, including off-label.1 Medical malpractice lawsuits alleging negligence in prescribing practices, such as off-label prescribing, typically include allegations against the psychiatrist for failure to4:

  • adequately assess the patient
  • consult the patient’s medical records
  • obtain informed consent from the patient
  • appropriately prescribe a medication for the clinical indication, dosage, patient’s age, etc.
  • monitor for adverse effects and therapeutic effectiveness.

Steps to minimize your risk

When prescribing a medication off-label, the following approaches can help reduce your liability risk:

Conduct a comprehensive clinical assess­ment. This should include requesting and reviewing your patient’s medical records.

Explain your motivation. Explain to your patient how prescribing an off-label medication can directly benefit him/her. Make it clear that you are not conducting experimental research by prescribing off-label because some patients might perceive this as a covert form of research.

Know the medications you prescribe. Although this sounds obvious, psychiatrists should thoroughly understand how each medication they prescribe is likely to clinically affect their patient. This information is available from many sources, including the FDA’s medication information sheets and the manufacturer’s medication package inserts. If possible, make sure that your off-label prescribing is supported by reputable, peer-reviewed literature.

Obtain informed consent. Tell your patient that the medication you are recommending is being prescribed off-label. Discuss the medication’s risks, benefits, adverse effects, associated “black-box” warnings, off-label uses, and alternatives to the off-label medication.4 Allow time for the patient to ask questions about these treatments.

Continue to: Document all steps

Pages

Recommended Reading

Psychiatric emergency? What to consider before prescribing
MDedge Psychiatry
COVID-19 vaccine supply will be limited at first, ACIP says
MDedge Psychiatry
FDA approves point-of-care COVID-19 antigen test
MDedge Psychiatry
Mitigating psychiatric disorder relapse in pregnancy during pandemic
MDedge Psychiatry
Attempted suicide in high school America, 2019
MDedge Psychiatry
Mortality burden of dementia may be greater than estimated
MDedge Psychiatry
SARS-CoV-2 appears unlikely to pass through breast milk
MDedge Psychiatry
NYC public hospitals rose to the demands of the COVID-19 crisis
MDedge Psychiatry
Two PR employees at FDA fired after plasma therapy controversy
MDedge Psychiatry
FDA expands remdesivir use for all COVID-19 hospitalized patients
MDedge Psychiatry